VanEck Pharmaceutical ETF (PPH)

NasdaqGM

119.64
+2.72 (+2.33%)
Updated Oct 30, 4:54 PM ET
AI Rating
Buy
Overall Score
76
Trend
77
Momentum
79
Risk
71

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 17, 2025 260 sessions Oct 29, 2026

AI Analysis

VanEck Pharmaceutical ETF is trading at $119.64, up 2.33% on the session. The 50 day average sits at $112.34 and the 200 day at $107.65, which puts the stock in a uptrend. RSI is at 58, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $112.30 with resistance near $116.73, so that band frames the current range. Average daily movement is roughly $1.99, or about 1.7% of the share price, which is what any stop placement has to allow for. The overall health score of 76 out of 100 combines a trend score of 77, momentum of 79 and a risk score of 71.

Technical indicators

RSI (14)
58.0
strong
MACD
1.246
bullish crossover
SMA 20
111.56
SMA 50
112.34
SMA 200
107.65
uptrend
ATR (14)
1.99
avg daily range
Support
112.30
Resistance
116.73
Volume vs 20d
0.56x
below average
Volatility
20.2%
annualised
1 month
+3.44%
3 months
+3.25%

About VanEck Pharmaceutical ETF

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.